These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19791576)

  • 1. [Thrombosis of stents with an antiproliferative coating. Review of the literature].
    Krylov AL
    Angiol Sosud Khir; 2009; 15(1):59-66. PubMed ID: 19791576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience in using stents with an antiproliferative coating in treatment of stenoses and occlusions of coronary arteries. Review of the literature].
    Krylov AL
    Angiol Sosud Khir; 2008; 14(4):75-81. PubMed ID: 19791556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problem of restenosis inside stents with an antiproliferative coating].
    Krylov AL; Maslov LN
    Angiol Sosud Khir; 2008; 14(2):45-51. PubMed ID: 19156050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
    Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting real with drug-eluting stents: 5-year follow up of a real-world cohort.
    Sakhuja R; Bhatt DL
    Am Heart J; 2009 May; 157(5):802-4. PubMed ID: 19376303
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of drug-eluting stent restenosis with another drug-eluting stent: do not fail the second time!].
    Colombo A; Latib A
    Rev Esp Cardiol; 2008 Nov; 61(11):1120-2. PubMed ID: 19000485
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting.
    Cuisset T; Frere C; Quilici J; Gaborit B; Bali L; Poyet R; Faille D; Morange PE; Alessi MC; Bonnet JL
    Am Heart J; 2009 May; 157(5):889-93. PubMed ID: 19376317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel antiplatelet therapies following percutaneous coronary interventions.
    Ahrens I; Bode C
    Curr Opin Investig Drugs; 2009 Sep; 10(9):902-11. PubMed ID: 19705332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 14. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.
    Nakazawa G; Finn AV; Vorpahl M; Ladich E; Kutys R; Balazs I; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2009 Nov; 54(21):1924-31. PubMed ID: 19909872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokine-eluting stents as new drug-delivery devices for angiogenic therapy].
    Grundmann S; Hoefer I; Bode C
    Hamostaseologie; 2008 Oct; 28(4):195-202. PubMed ID: 18836644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: vertebral ostium stenting: unsolved puzzle.
    Lin YH; Kao HL
    J Endovasc Ther; 2010 Apr; 17(2):241-2. PubMed ID: 20426647
    [No Abstract]   [Full Text] [Related]  

  • 18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The drug-eluting stent (DES) market.
    Waksman R
    Cardiovasc Revasc Med; 2008; 9(3):131. PubMed ID: 18606374
    [No Abstract]   [Full Text] [Related]  

  • 20. Stent thrombosis: an issue revisited in a changing world.
    Honda Y; Fitzgerald PJ
    Circulation; 2003 Jul; 108(1):2-5. PubMed ID: 12847051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.